Analyse @YaleCancer's tweets
@YaleCancer
| 15,260 followers
.@DanielPetrylak will present data at #ASCO20 showing clinical evidence of anti-tumor activity with metastatic castration-resistant #prostatecancer (mCRPC) using a PROTAC protein degrader ARV-110 in a phase I trial. @SmilowCancer @YaleMed @YNHH #oncoalert https://t.co/qE8aEEqtWI https://t.co/3qeO1d6eGo